SARA MOORE: Open Payments
NPI 1093266520 · CLINTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 56 payments from 19 companies in 2025. Trend: 2023 $1,731 · 2024 $1,175 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $200 |
| AstraZeneca Pharmaceuticals LP | 7 | $193 |
| Lilly USA, LLC | 11 | $158 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $61 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Lundbeck LLC | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $27 |
| Alkermes, Inc. | 1 | $26 |
Products named: UBRELVY, MOUNJARO, BREZTRI, REXULTI, FARXIGA, VOQUEZNA, QULIPTA, Auvelity.
Industry payments across SC — which companies pay providers there.
